Solventum (SOLV): Director received 3,300 units
Carlos Alban, Director at Solventum, reported a grant / award of 3,300 units.
- 3,300
- Derivative units
- Traded
- May 15, 2026
- Filed
- May 18, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 3, 2024CongressDisclosed sale of SOLV — reported range $1,001 - $15,000
- Mar 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.”
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of SOLV — reported range $1,001 - $15,000
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.3%
- May 5, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- May 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026.”
- Jul 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026.”
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Solventum
For Solventum, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOLV page.
How this filing works
Explore the data
Common questions
Which Solventum (SOLV) insider traded, and how much?
Carlos Alban, Director at Solventum, reported a grant / award of 3,300 units. Not an open-market trade.
When did it happen, and when was it made public?
Traded: May 15, 2026. Filed: May 18, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Solventum recently?
For Solventum, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the SOLV page.
Does this mean SOLV stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Solventum
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRAug 7, 2026
- SEC Form 13F-HRAug 6, 2026
- Senate eFD periodic transaction reportAug 5, 2026
Everything OQRO holds on this company is on its SOLV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
